Lung Cancer Europe is pleased to support the upcoming “From Testing to Targeted Treatments (FT3)”
Lung Cancer Europe shared a post on LinkedIn:
“Too many people with lung cancer still don’t have access to the testing or treatment they need.
Lung Cancer Europe is pleased to support the upcoming From Testing to Targeted Treatments (FT3) Town Hall on 23 April 2025, from 15:00 to 16:00 CET.
This online meeting will explore collaborative projects aimed at removing barriers and building practical, real-world solutions in precision medicine — directly impacting patient care.
The session will offer updates from across the FT3 community and ways to get involved in making systemic change possible.
It’s open to advocates, clinicians, researchers, and anyone working to improve access to testing and targeted treatments.
FT3’s mission to make precision medicine equally accessible aligns with LuCE’s commitment to improving outcomes for lung cancer patients across Europe.
We’re grateful to From Testing to Targeted Treatments (FT3) for hosting this important conversation and bringing the community together around shared challenges and solutions.
You can register here.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023